Actively Recruiting
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
Led by North American Science Associates Ltd. · Updated on 2025-11-24
126
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
Sponsors
N
North American Science Associates Ltd.
Lead Sponsor
N
Next Biomedical Co., Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
CONDITIONS
Official Title
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient has localized knee pain
- Must be an appropriate candidate for arterial vascular access procedure
You will not qualify if you...
- Known sensitivity or allergy to implant materials
- Unable or unwilling to comply with study requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Virginia
Charlottesville, Virginia, United States, 22903
Actively Recruiting
Research Team
Z
Ziv J Haskal, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here